The ISCHEMIA trial has caused heated discussion in the cardiovascular field, with its results being used to downgrade coronary artery bypass grafting (CABG) recommendations in recent guidelines. The authors of this paper performed a detailed re-analysis of the ISCHEMIA trial and critically examined its findings.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary disease
December 14, 2023
December 7, 2023
In this study, the authors performed a propensity matched analysis of hospital costs for robotic-assisted CABG vs. conventional CABG. 1,173 patients were included in the analysis from 2018 until 2021. Decision regarding intervention modality was decided by the treating surgeon.
November 30, 2023
This Novo Nordisk funded, multicenter, double blind, randomized, placebo-controlled trial explored whether semaglutide (a glucagon-like peptide-1 receptor agonist) can reduce cardiovascular risk associated with overweight and obesity in the absence of diabetes.
November 20, 2023
The elderly population is exponentially increasing worldwide, leading to a higher incidence of coronary artery disease. The growing number of elderly patients is closely related to a higher incidence of frailty.
November 16, 2023
This video demonstrates the challenges of a successful surgical repair of a giant right coronary artery aneurysm measuring approximately 6 cm.
October 31, 2023
This video demonstrates the authors’ technique for radial artery harvesting using the harmonic scalpel, how methylene blue dye can help maintain vessel orientation, and a "squirt test" for intraoperative confirmation of ulnar collateral blood flow.
October 26, 2023
The authors performed a systematic review of the evidence supporting the use of different conduits for CABG. Their overall conclusion was that coronary artery bypass grafting strategy must be individualized. The radial artery (RA) graft has better patency rates and fewer adverse cardiac events compared with saphenous vein graft (SVG).
September 28, 2023
Use of antiplatelet medication following coronary artery bypass grafting is common practice to reduce thrombotic events. However, antiplatelet resistance is of growing concern. The authors of this review conducted a systematic review and meta-analysis of eleven studies involving 3122 patients.
August 30, 2023
Survival of diabetics after single or multiple coronary artery bypass grafting was compared in a national database over twenty years with 69,224 patients. End points were long-term all-cause mortality and thirty-day clinical outcomes. 17,474 nondiabetic and 10,989 diabetic matched pairs were generated.
August 11, 2023
This article provides a systematic review of the choice of conduits for coronary artery bypass grafting and has been endorsed by both the STS and EACTS. The review reports on a variety of factors related to specific conduits, from patency and clinical outcomes to harvesting and target vessel selection.